Johnson & Johnson announced definitive agreement to acquire Cougar Biotechnology. The company will initiate a tender offer to buy all outstanding shares of Cougar Biotechnology at $43 per share. The Boards of both Johnson & Johnson and Cougar Biotechnology have approved the transaction. The deal is expected to close in the third quarter of 2009.
Ineos CEO Ineos calls on European politicians to save the chemical industry.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
